Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4666 to 4680 of 7684 results

  1. What is the clinical and cost effectiveness of levothyroxine (T4) and liothyronine (T3) combination therapy compared with T4 alone for people with hypothyroidism whose symptoms have not responded sufficiently to T4 alone? Does DiO2 polymorphism affect the response to combination therapy with T4 and T3?

    Recommendation ID NG145/1 Question What is the clinical and cost effectiveness of levothyroxine (T4) and liothyronine (T3) combination

    Research recommendation
    Published
    10 February 2020

  2. What is the effectiveness of laparoscopic fundoplication compared with medical management in people with GORD that does not respond to optimal proton pump inhibitor (PPI) treatment?

    Recommendation ID CG184/2 Question What is the effectiveness of laparoscopic fundoplication compared with medical management in people

    Research recommendation
    Published
    15 November 2019

  3. Lifestyle interventions (diet and exercise):- Are specialist lifestyle interventions (diet and exercise) effective, compared with no specialist lifestyle interventions, for women with endometriosis?

    Recommendation ID NG73/3 Question Lifestyle interventions (diet and exercise):- Are specialist lifestyle interventions (diet and exercise)

    Research recommendation
    Published
    15 October 2018

  4. Laparoscopic fundoplication compared with medical management:- What is the effectiveness of laparoscopic fundoplication compared with medical management in people with GORD that does not respond to optimal proton pump inhibitor (PPI) treatment?

    Recommendation ID CG184/2 Question Laparoscopic fundoplication compared with medical management:- What is the effectiveness of laparoscopic

    Research recommendation
    Published
    9 June 2015

  5. Lifestyle interventions:- How effective and cost effective are different types (and levels and frequency) of physical activity in reducing short- and long-term blood glucose levels and preventing or delaying type 2 diabetes? How does this vary for different subgroups, for example, different black and minority ethnic groups and people of different ages, for example, aged 18–24, 25–39 and 75 and over?

    Recommendation ID PH38/6 Question Lifestyle interventions:- How effective and cost effective are different types (and levels and frequency)

    Research recommendation
    Published
    9 June 2015

  6. Lifestyle interventions:- How effective and cost effective are different types of dietary regime in reducing short- and long-term blood glucose levels and preventing or delaying type 2 diabetes? How does this vary for different subgroups, for example, African-Caribbean and black African and other minority ethnic groups and for people of different ages, for example, aged 18–24, 25–39 and 75 and over?

    Recommendation ID PH38/5 Question Lifestyle interventions:- How effective and cost effective are different types of dietary regime in reducing

    Research recommendation
    Published
    9 June 2015

  7. Lifestyle interventions:- Which components of an intensive lifestyle-change programme contribute most to the effectiveness and cost effectiveness of interventions to prevent or delay type 2 diabetes in those at high risk? How does this vary for different black and minority ethnic groups, for people of different ages for example, aged 18–24, 25–39 and 75 and over, and for vulnerable adults?

    Recommendation ID PH38/4 Question Lifestyle interventions:- Which components of an intensive lifestyle-change programme contribute most

    Research recommendation
    Published
    9 June 2015

  8. What is the effectivness of stains and/or other lipid-lowering treatment in people with type 1 diabetes?

    Recommendation ID NG238/3 Question What is the effectivness of stains and/or other lipid-lowering treatment in people with type 1 diabetes

    Research recommendation
    Published
    3 May 2024

  9. What is the clinical effectiveness and safety of differing doses of lipid-modifying therapy in children with FH?

    Recommendation ID CG71/3 Question What is the clinical effectiveness and safety of differing doses of lipid-modifying therapy in children

    Research recommendation
    Published
    15 November 2019

  10. Liver disease:- Should all children with meconium ileus receive ursodeoxycholic acid from diagnosis?

    Recommendation ID NG78/1 Question Liver disease:- Should all children with meconium ileus receive ursodeoxycholic acid from diagnosis?

    Research recommendation
    Published
    18 October 2018

  11. Local coordination:- In the UK, what are the key components of a local coordination role to ensure best value for money in promoting older people's independence and mental wellbeing?

    Recommendation ID NG32/3 Question Local coordination:- In the UK, what are the key components of a local coordination role to ensure best

    Research recommendation
    Published
    25 January 2016

  12. What is the long-term effectiveness of bladder wall injection with botulinum toxin type A for overactive bladder in women?

    Recommendation ID NG123/6 Question What is the long-term effectiveness of bladder wall injection with botulinum toxin type A for overactive

    Research recommendation
    Published
    21 June 2019

  13. What is the clinical and cost effectiveness of treatment (antithyroid drugs or radioactive iodine) for improving long-term health outcomes for people with subclinical hyperthyroidism?

    Recommendation ID NG145/2 Question What is the clinical and cost effectiveness of treatment (antithyroid drugs or radioactive iodine) for

    Research recommendation
    Published
    10 February 2020

  14. Long-term safety of tenofovir disoproxil in chronic hepatitis B:- Further research should be undertaken to determine the long-term safety of tenofovir disoproxil, including the risk of clinically significant hypophosphataemia and related bone toxicity, in people with chronic hepatitis B. The cost effectiveness of routine monitoring for phosphate loss and bone disease in people with chronic hepatitis B who are receiving tenofovir disoproxil treatment needs further evaluation.

    Recommendation ID CG165/3 Question Long-term safety of tenofovir disoproxil in chronic hepatitis B:- Further research should be undertaken

    Research recommendation
    Published
    9 June 2015

  15. Long-term outcomes for children and young people displaying harmful sexual behaviour:- What are the long-term outcomes for children and young people displaying harmful sexual behaviour, when should practitioners intervene and what potentially modifiable factors have the most important impact?

    Recommendation ID NG55/1 Question Long-term outcomes for children and young people displaying harmful sexual behaviour:- What are the long-term

    Research recommendation
    Published
    17 October 2016